Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

fibrosis/fatigue

Krækjan er vistuð á klemmuspjaldið
9 niðurstöður

Compositions and methods for treating intestinal hyperpermeability

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability. BACKGROUND The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the

Composition and methods for treating intestinal hyperpermeability

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability. BACKGROUND The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the

Compositions and methods for treating intestinal hyperpermeability

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability. BACKGROUND The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the

Compositions and methods for treating intestinal hyperpermeability

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability. BACKGROUND The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the

Compositions and methods for treating intestinal hyperpermeability

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability. BACKGROUND The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the

Compositions and methods for treating intestinal hyperpermeability

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability. BACKGROUND The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the

Treatment and prevention of Th1 and `autoimmune` diseases effected with antibiotics and/or angiotensin inhibition

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF INVENTION It is currently believed that the diseases known as "autoimmune" diseases are caused by the body's immune system attacking the body itself. But I have discovered that these so-called "autoimmune" diseases are actually caused by stealthy intra-cellular bacteria. I have

Probiotic Bifidobacterium adolescentis strains

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention relates to novel isolated strains of Bifidobacterium adolescentis which are capable of i) increasing the trans-epithelial electrical resistance (TER) of a Caco-2 cell monolayer after 10 h treatment to more than 120% of TER at treatment start, ii) inducing

Beta-casein A2 and antioxidant capacity

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The invention relates to the milk protein A2 beta-casein and improving the antioxidant capacity in an animal by increasing the levels of glutathione in the body of the animal. In particular, the invention relates to milk and milk derived food products. The applicant has found that
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge